Le Lézard
Classified in: Health, Science and technology
Subjects: NEW PRODUCTS/SERVICES, CALENDAR OF EVENTS, HEALTH, LIFESTYLE, TRADE SHOWS/SEMINARS/WEBINARS

BOAZ to Honour Human Potential with Handcrafted Art Installation at HempFest Edmonton


EDMONTON, Alberta, Feb. 26, 2019 (GLOBE NEWSWIRE) -- BOAZ Pharmaceuticals Inc. (BOAZ) received its license for cultivation in June 2018, and the company is now gearing up for Phase II of expansion as it is in the final stages of obtaining its Sales License. A labour of love is one way to describe the exigent process BOAZ has endured as the independent Licensed Producer (LP) continues to scale.

"It's a unique skill set to be able to put the right structures, systems, processes, and schedules into place while building and motivating a new team to advance a complex regulatory-driven project on a very tight timeline," explains David Isaak, President, and CEO of BOAZ.

BOAZ is known for having earned its LP status in only 10 months without external consultancy, under the Access to Cannabis for Medical Purposes Regulations (ACMPR): the fastest processing time of any facility across Canada. This achievement required great focus and commitment from the entire BOAZ team, and so it comes as no surprise that every detail in the producer's refreshed identity system received the same passionate care and attention that was summoned to earn its LP status.

From a new website to a refreshed logo, BOAZ wanted to honour the sheer perseverance of human potential and pay tribute to the craft process. To highlight its intention, BOAZ also tapped into the creative talents of Calgary-based artist, Carl White, to handcraft a unique piece that fans can truly appreciate and relate to.

"The project has been nurtured and hand built from the ground up. Every leaf was hand carved. I'm proud that we are matching the vision of BOAZ through this," says Carl White, Artist. The cannabis-themed art installation took approximately 100 hours to craft from concept to execution. It pays homage to the meticulous care that BOAZ puts into handcrafting its medical cannabis products.

The handcrafted art installation will be on display at the upcoming HempFest Cannabis Expo in Edmonton, Alberta. In addition to admiring another example of fine Alberta craftsmanship, guests can talk with team members and interact with the display.

The BOAZ team will be stationed at Booth #3 on March 2nd and 3rd, 2019. HempFest Cannabis Expo will be held at the Edmonton Convention Centre. To learn more and purchase tickets, visit https://www.hempfestedmonton.com/.

BOAZ: We're Growing Potential.

About BOAZ

BOAZ Pharmaceuticals Inc. is a privately-owned, Licensed Producer of cannabis. Based in Calgary, Alberta, BOAZ received its official license for cultivation from Health Canada on June 22, 2018. The 20,000 sq. ft. medical marijuana facility began production on July 26, 2018, and has a Sales License in the final stages of application. Media resources available upon request.

Media Contact: David Isaak
President and CEO, Calgary
Email: [email protected]
Phone: 250-262-9410 (Direct Line)

Media Contact: Alison Masniuk
Media Coordinator for BOAZ
Email: [email protected]
Phone: 403-993-9879



These press releases may also interest you

at 04:05
True, the only tech and data-first global talent platform, today announced its partnership with Leadership Circle, a leading global provider of executive coaching, assessments, and advisory services. This collaboration marks a significant step for...

at 04:05
Veritonic, the industry's comprehensive audio research and analytics platform, announced today an integration with SaaS mobile marketing analytics and attribution platform, AppsFlyer. This integration empowers Veritonic's audio attribution solution...

at 04:00
Following the conclusion of a successful pilot, Cambridge University Press is expanding the rollout of Cassyni journal seminar series to more journals in their portfolio. The series enable Cambridge to grow researcher communities around its journals,...

at 04:00
Gcore, the global edge AI, cloud, network, and security solutions provider, today announced its recognition as 'Highly Commended' in the Industry Innovation category at the NVIDIA Partner Network Awards EMEA 2024 for its groundbreaking Speech-to-Text...

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...



News published on and distributed by: